Activated Clotting Time Testing Market to undergo a CAGR of 4.6%, size, share, future growth

The activated clotting time (ACT) is a test that is utilized mainly to monitor high doses of unfractionated (standard) heparin therapy. Heparin is a drug that prevents the blood clotting (anticoagulant) and is generally given intravenously (IV) by injection or by continuous infusion. High doses of heparin may be given during processes that require the blood to be prevented from clotting, like the heart bypass surgery.

View Detailed Report" https://www.databridgemarketresearch.com/reports/global-activated-clotting-time-testing-market

Data Bridge Market Research analyses that the global activated clotting time testing market which was USD 447.64 million in 2022, is expected to reach USD 643.93 million by 2030, and is expected to undergo a CAGR of 4.6% during the forecast period 2023-2030. This indicates the market value. "Clinical Laboratory Analyzer" dominates the product type segment of the global activated clotting time testing market owing to the growing demand for better and precise methods for diagnosis in patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Activated Clotting Time Testing Market Dynamics

Opportunities

Increasing Adoption of Point-of-Care Testing

Point-of-care testing (POCT) is gaining popularity due to its ability to provide immediate results at the patient's bedside or in outpatient settings. ACT testing at the point of care offers the opportunity for rapid and real-time monitoring of clotting time, enabling prompt adjustments in anticoagulant therapy and reducing the risk of bleeding or thrombotic events.

Drivers

Increasing Prevalence of Cardiovascular Diseases

Cardiovascular diseases, such as atrial fibrillation, deep vein thrombosis, and coronary artery disease, are major contributors to morbidity and mortality worldwide. The need for accurate and timely monitoring of clotting time in patients with these conditions drives the demand for ACT testing.

Application

Cardiovascular and Vascular Surgery

ECMO

Cardiac Catheterization Laboratories

Critical Care Units

Hemodialysis Units

Technology

Optical Detection

Laser Based Detection

Mechanical Detection

Fluorescent Based Detection

Some of the major players operating in the global activated clotting time testing market are:

F. Hoffmann-La Roche Ltd (Switzerland)

Siemens (Germany)

Thermo Fisher Scientific (U.S.)

Abbott (U.S.)

Helena Laboratories Corporation (U.S.)

Sysmex Corporation (Japan)

NIHON KOHDEN CORPORATION (Japan)

Instrumentation Laboratory India Pvt ltd (India)

Medtronic (Ireland)

Explore More Reports:

https://databridgemarketresearchreports.blogspot.com/2024/06/alcohol-sensor-market-to-reach-value-of.html

https://databridgemarketresearchreports.blogspot.com/2024/06/edge-computing-market-to-reach-usd.html

https://databridgemarketresearchreports.blogspot.com/2024/06/caprolactam-market-to-reach-usd-2577.html

https://databridgemarketresearchreports.blogspot.com/2024/06/retail-ready-packaging-market-to-grow.html

About Data Bridge Market Research:

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

Contact Us: -
Data Bridge Market Research
US: +1 614 591 3140
United Kingdom: +44 845 154 9652
APAC: +653 1251 975
Email: - sopan.gedam@databridgemarketresearch.com

This release was published on openPR.